Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hot Flashes Medicine & Life Sciences
Cytochrome P-450 CYP2D6 Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2017

Combination epigenetic therapy in advanced breast cancer with 5-azacitidine and entinostat: A phase II national cancer institute/stand up to cancer study

Connolly, R. M. , Li, H. , Jankowitz, R. C. , Zhang, Z. , Rudek, M. A. , Jeter, S. C. , Slater, S. A. , Powers, P. , Wolff, A. C. , Fetting, J. H. , Brufsky, A. , Piekarz, R. , Ahuja, N. , Laird, P. W. , Shen, H. , Weisenberger, D. J. , Cope, L. , Herman, J. G. , Somlo, G. , Garcia, A. A. & 5 others Jones, P. A., Baylin, S. B., Davidson, N. E., Zahnow, C. A. & Stearns, V. Jun 1 2017 In : Clinical Cancer Research. 23, 11, p. 2691-2701 11 p.

Research output: Research - peer-reviewArticle

Azacitidine
National Cancer Institute (U.S.)
Epigenomics
Breast Neoplasms
Neoplasms

Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer

Robarge, J. D., Desta, Z., Nguyen, A. T., Li, L., Hertz, D., Rae, J. M., Hayes, D. F., Storniolo, A. M., Stearns, V., Flockhart, D. A., Skaar, T. C. & Henry, N. L. Feb 1 2017 In : Breast Cancer Research and Treatment. 161, 3, p. 453-461 9 p.

Research output: Research - peer-reviewArticle

exemestane
letrozole
Estrogens
Breast Neoplasms
Therapeutics

Individualized Molecular Analyses Guide Efforts (IMAGE): A prospective study of molecular profiling of tissue and blood in metastatic triple-negative breast cancer

Parsons, H. A. , Beaver, J. A. , Cimino-Mathews, A. , Ali, S. M. , Axilbund, J. , Chu, D. , Connolly, R. M. , Cochran, R. L. , Croessmann, S. , Clark, T. A. , Gocke, C. D. , Jeter, S. C. , Kennedy, M. R. , Lauring, J. , Lee, J. , Lipson, D. , Miller, V. A. , Otto, G. A. , Rosner, G. L. , Ross, J. S. & 10 others Slater, S., Stephens, P. J., Vandenberg, D. A., Wolff, A. C., Young, L. E., Zabransky, D. J., Zhang, Z., Zorzi, J., Stearns, V. & Park, B. H. Jan 15 2017 In : Clinical Cancer Research. 23, 2, p. 379-386 8 p.

Research output: Research - peer-reviewArticle

Triple Negative Breast Neoplasms
Prospective Studies
Neoplasms
Biopsy
Therapeutics

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors

Kadakia, K. C., Kidwell, K. M., Seewald, N. J., Snyder, C. F., Storniolo, A. M., Otte, J. L., Flockhart, D. A., Hayes, D. F., Stearns, V. & Henry, N. L. Apr 27 2017 (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Research - peer-reviewArticle

Aromatase Inhibitors
Estradiol
Pharmaceutical Preparations
Patient Reported Outcome Measures
exemestane

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

Wu, X., Zahari, M. S., Renuse, S., Kelkar, D. S., Bharbuiya, M. A., Rojas, P. L., Stearns, V., Gabrielson, E., Malla, P., Sukumar, S., Mahajan, N. P. & Pandey, A. 2017 In : Oncotarget. 8, 2, p. 2971-2983 13 p.

Research output: Research - peer-reviewArticle

Triple Negative Breast Neoplasms
Protein-Tyrosine Kinases
Breast Neoplasms
Therapeutics
Neoplasms